288 related articles for article (PubMed ID: 33466431)
1. NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features.
Gardoni F; Stanic J; Scheggia D; Benussi A; Borroni B; Di Luca M
Cells; 2021 Jan; 10(1):. PubMed ID: 33466431
[TBL] [Abstract][Full Text] [Related]
2. Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure.
Palese F; Bonomi E; Nuzzo T; Benussi A; Mellone M; Zianni E; Cisani F; Casamassa A; Alberici A; Scheggia D; Padovani A; Marcello E; Di Luca M; Pittaluga A; Usiello A; Borroni B; Gardoni F
Neurobiol Aging; 2020 Feb; 86():143-155. PubMed ID: 31784278
[TBL] [Abstract][Full Text] [Related]
3. Neuronal central nervous system syndromes probably mediated by autoantibodies.
Chefdeville A; Honnorat J; Hampe CS; Desestret V
Eur J Neurosci; 2016 Jun; 43(12):1535-52. PubMed ID: 26918657
[TBL] [Abstract][Full Text] [Related]
4. Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
Levite M; Zelig D; Friedman A; Ilouz N; Eilam R; Bromberg Z; Ramadhan Lasu AA; Arbel-Alon S; Edvardson S; Tarshish M; Riek LP; Lako RL; Reubinoff B; Lebendiker M; Yaish D; Stavsky A; Galun E
J Autoimmun; 2020 Aug; 112():102462. PubMed ID: 32561150
[TBL] [Abstract][Full Text] [Related]
5. Glutamate Receptor Antibodies in Autoimmune Central Nervous System Disease: Basic Mechanisms, Clinical Features, and Antibody Detection.
Scotton WJ; Karim A; Jacob S
Methods Mol Biol; 2019; 1941():225-255. PubMed ID: 30707437
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune epilepsy: distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA.
Ganor Y; Goldberg-Stern H; Lerman-Sagie T; Teichberg VI; Levite M
Epilepsy Res; 2005 Jun; 65(1-2):11-22. PubMed ID: 15978777
[TBL] [Abstract][Full Text] [Related]
7. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.
Steiner J; Walter M; Glanz W; Sarnyai Z; Bernstein HG; Vielhaber S; Kästner A; Skalej M; Jordan W; Schiltz K; Klingbeil C; Wandinger KP; Bogerts B; Stoecker W
JAMA Psychiatry; 2013 Mar; 70(3):271-8. PubMed ID: 23344076
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.
Schou M; Sæther SG; Borowski K; Teegen B; Kondziella D; Stoecker W; Vaaler A; Reitan SK
Psychol Med; 2016 Dec; 46(16):3303-3313. PubMed ID: 27609625
[TBL] [Abstract][Full Text] [Related]
9. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.
Mikasova L; De Rossi P; Bouchet D; Georges F; Rogemond V; Didelot A; Meissirel C; Honnorat J; Groc L
Brain; 2012 May; 135(Pt 5):1606-21. PubMed ID: 22544902
[TBL] [Abstract][Full Text] [Related]
10. [Autoimmune mechanisms of modulation of the activity of glutamate receptors in children with epilepsy and craniocerebral injury].
Pinelis VG; Sorokina EG
Vestn Ross Akad Med Nauk; 2008; (12):44-51. PubMed ID: 19189459
[TBL] [Abstract][Full Text] [Related]
11. [Levels of autoantibodies to glutamate receptors and immunological blood parameters in patients with epilepsy].
Bazarova VG; Granstrem OK; Dambinova SA
Vopr Med Khim; 2002; 48(4):381-7. PubMed ID: 12506615
[TBL] [Abstract][Full Text] [Related]
12. Synaptic localization of ionotropic glutamate receptors in the rat substantia nigra.
Chatha BT; Bernard V; Streit P; Bolam JP
Neuroscience; 2000; 101(4):1037-51. PubMed ID: 11113353
[TBL] [Abstract][Full Text] [Related]
13. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune Epilepsy - Novel Multidisciplinary Analysis, Discoveries and Insights.
Levite M; Goldberg H
Front Immunol; 2021; 12():762743. PubMed ID: 35095841
[TBL] [Abstract][Full Text] [Related]
15. Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients.
Jézéquel J; Johansson EM; Dupuis JP; Rogemond V; Gréa H; Kellermayer B; Hamdani N; Le Guen E; Rabu C; Lepleux M; Spatola M; Mathias E; Bouchet D; Ramsey AJ; Yolken RH; Tamouza R; Dalmau J; Honnorat J; Leboyer M; Groc L
Nat Commun; 2017 Nov; 8(1):1791. PubMed ID: 29176681
[TBL] [Abstract][Full Text] [Related]
16. Peripheral neuropathy in limbic encephalitis with anti-glutamate receptor antibodies: Case report and systematic literature review.
Wei YC; Huang CC; Liu CH; Kuo HC; Lin JJ
Brain Behav; 2017 Sep; 7(9):e00779. PubMed ID: 28948076
[TBL] [Abstract][Full Text] [Related]
17. Detection of antibodies to opioid and glutamate receptors by latex agglutination and enzyme immunoassay.
Kharitonova AV; Menshikova AY; Evseeva TG; Chekina NA; Bychkov ER; Skulyabin DI; Dambinova SA
Bull Exp Biol Med; 2005 Jan; 139(1):81-4. PubMed ID: 16142284
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune seizures and epilepsy.
Geis C; Planagumà J; Carreño M; Graus F; Dalmau J
J Clin Invest; 2019 Mar; 129(3):926-940. PubMed ID: 30714986
[TBL] [Abstract][Full Text] [Related]
19. [THE ROLE OF AUTOANTIBODIES TO THE EXTRACELLULAR REGIONS OF IONOTROPIC RECEPTORS IN ETIOLOGY AND PATHOGENESIS OF AUTOIMMUNE DISEASES].
Zharova OA; Shpakov AO
Ross Fiziol Zh Im I M Sechenova; 2016 Jul; 102(7):773-91. PubMed ID: 30193046
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
